| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907467 | Experimental Hematology | 2009 | 14 Pages |
Abstract
This study demonstrates that previously cryopreserved and rethawed CB MNCs can be EvE up to 7 days to yield viable and activated NK and NKT-like subsets that appear to be cytolytic based on the cell repertoire and could be utilized in the future as adoptive cellular immunotherapy post-unrelated CB transplantation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Janet Ayello, Carmella van de Ven, Evan Cairo, Jessica Hochberg, Laxmi Baxi, Prakash Satwani, Mitchell S. Cairo,